Sofregen Medical
Sofregen
Cambridge, United States · Founded 2015
- Headquarters
- Cambridge
- Founded
- 2015
- Business Model
- B2B
- Website
- sofregen.com
- Last Round
- Series BSep 2016
- Rounds
- 3
About
Sofregen is a biomaterials company that grew out of silk protein research at Tufts University's Biomedical Engineering Department, developing a highly purified silk protein platform for regenerative medicine. Its FDA-cleared products include the SERI Surgical Scaffold (cleared 2013, acquired by Sofregen in 2016) and the Silk Voice injectable implant (cleared 2019) for vocal fold medialization, both designed to support tissue regeneration in aesthetic and reconstructive surgical procedures.
Summary
Sofregen Medical is a Biotech company based in Cambridge, United States, founded in 2015. Its most recent funding was a Series B round in Sep 2016. Investors include Polaris Partners.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Sep 2016
Sign up to see all 4 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...